ABCL
AbCellera Biologics Inc. · Healthcare
Director Michael R Hayden bought $481K of AbCellera Biologics Inc.
Bought$481,033
$10.37Price
46,387Shares
+4%Stake
What ABCL did for a copier
- $1,000 copied at Fri, Aug 14 close, $11.38
- $1,302
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Sep 29 close.
Michael R Hayden's record
5 other buys with 3 months of prices since 2017: on average −12.0% against the S&P 500, and 2 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 12. Filed Fri, Aug 14, 11:50 AM ET, during the session. Returns use the Aug 14 close and the Sep 29 close. Not investment advice.